Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 151 clinical trials
Evaluation of Clinical Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)

The aim of this study is the characterization from epidemiological, radiomics and molecular point of view of lung metastasis of patients at beginning affected by pancreatic adenocarcinoma (PDAC), which after the resection of primitive tumor have met with initial recurrence of the disease exclusively at the lung level.

metastasis
pancreatic adenocarcinoma
primary tumor
pdac
adenocarcinoma
  • 0 views
  • 19 Feb, 2024
Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC

Immunotherapy for PD-L1 positive patients is still ineffective in some patientswhich may be related to the complex immune microenvironment.In view of this bottleneck, further refinement of immunotyping and in-depth study of drug resistance mechanism are the most important tasks. In this observational study, we evaluated the difference of gene mutation …

small cell lung cancer
  • 0 views
  • 19 Feb, 2024
Point of Care Ultrasound to Evaluate Diaphragmatic Function in Children Undergoing Thoracic Surgery

In addition, we examine if there is a relationship between diaphragmatic dysfunction and pulmonary complications, including postoperative lung atelectasis.

  • 0 views
  • 19 Feb, 2024
Transgender Men Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC

The study will focus on: Cardiovascular status and lung function Body composition Mental health and quality of life Establishing a biobank for later use.

  • 0 views
  • 19 Feb, 2024
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib

To determine whether in patients with EGFR mutated advanced NSCLC and osimertinib as first-line treatment, the (repeated) use of LAT to 3 OP lesions and continuation of first-line osimertinib, improves the median progression-free survival by more than 3 months (i.e. PFS2-PFS1 = >3 months).

  • 0 views
  • 19 Feb, 2024
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer

Colorectal cancer is the third most frequent neoplasm after prostate and lung in man and breast and lung cancers in woman from Western Countries. The intensive study of predictive factors has strongly ameliorated the therapeutic flow-chart of metastatic colorectal cancer (mCRC) by allowing the selection of patients who benefit from …

EGFR
growth factor
aflibercept
bevacizumab
oxaliplatin
  • 0 views
  • 19 Feb, 2024
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )

In this phase, our study will include data sets of five types of cancers namely, breast, head and neck, brain, cervix and lung cancer. We propose to demonstrate the application of this data set in cancer research. We will work on serial PET-CT based radiomics of breast and cervix cancer …

  • 0 views
  • 19 Feb, 2024
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins

The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related …

autoimmune disease
arthritis
immunosuppressive agents
  • 0 views
  • 19 Feb, 2024
COVID-19: Respiratory and Sleep Follow-up

The current project is a prospective, multicentric cohort study aiming at a multidisciplinary assessment (pulmonary, cardiometabolic, sleep and mental health) of the consequences of infection by SARS-CoV-2, 3 months after the diagnosis in order to better characterize these complications. 400 patients with a positive diagnosis of SARS-CoV-2 will be included …

covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
Intestinal Flora Research Plan for Critically Ill Patients

More and more critically ill patients have improved early survival, they have been suffering from organ damage and inflammation for a long time, which is called chronic critical illness (CCI). Among CCI, persistent inflammatory response-immunosuppression-catabolic syndrome (PICS) is a special type of chronic severe disease, and immune paralysis is its …

  • 0 views
  • 19 Feb, 2024